A multicenter study finds no difference in outcomes between frail and nonfrail elderly patients treated with tildrakizumab ...

The peak national body for community pharmacists wants to its members take on more responsibilities for community care in an ...

The biopharma’s campaign for the treatment, which received FDA approval late last year to treat HS, aims to help patients get back to daily activities.

Explore the benefits and challenges of swimming in different water types. Learn best practices for skin care before and after, including tips for moisturization.

Patients with severe psoriasis who were treated with TNFi long-term had a lower risk of developing PsA than those treated with phototherapy.

The analysis included data from 24 randomized clinical trials encompassing 12,661 patients. The findings revealed that interclass biologic switching in psoriasis treatment led to significantly ...

In partnership with the National Psoriasis Foundation, Boehringer Ingelheim has launched a new campaign to increase awareness and education for generalized pustular psoriasis (GPP). The campaign will ...

Dupilumab use for atopic dermatitis and other conditions was associated with an increased risk of incident psoriasis but not psoriatic arthritis.

Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...

Discover how switching biologics boosts psoriasis treatment effectiveness while managing safety risks. Read more here.

Psoriasis is a long-term disease that affects the immune system. It makes skin cells grow too fast. Instead of new cells ...

You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...